Navigation Links
Lend Lease Announces the Appointment of Tom Chapman as Director Operations for the Life Sciences Group in the Atlantic Region

RALEIGH, N.C., Jan. 26, 2012 /PRNewswire/ -- Lend Lease is pleased to announce the appointment of Tom Chapman as Director of Operations for the Life Sciences group in the Atlantic Region.  Tom rejoined Lend Lease on January 4, 2012, and will be based out of the Raleigh, NC office, working closely with the regional office heads and business development teams in the South Atlantic offices. He will report directly to Steve Eberling, Senior Vice President, Principal In Charge, Life Sciences and Princeton.

Tom has been in the Design and Construction industry  for over 33 years and has focused his career specifically on the  Life Science sector for the last 22 years. During this time, Tom has worked for Day & Zimmerman / Life Sciences for 8 Years, Turner Construction for 6 Years and most recently Jacobs for the past 9 years.   Prior to working at Jacobs, Tom worked for the legacy Bovis Lend Lease business within the Global Life Sciences Group in the Princeton, NJ office. 

Tom has completed mechanical design and engineering, and engineering courses from Villanova and Temple Universities and received a master certificate PMP project management from Villanova University.  His numerous professional affiliations include International Society for Pharmaceutical Engineering (ISPE) Delaware Valley Chapter, Design Build Institute of America, Project Management Institute and the Drexel University Construction Management Advisory Committee.

About Lend Lease

Lend Lease is a leading international property and infrastructure group. Listed on the Australian Securities Exchange and with circa 17,000 employees worldwide, Lend Lease's capabilities span the property and infrastructure spectrum.

The Americas region headquarters is located in New York. In the Americas we offer project management & construction, public partnerships, public-private partnerships, development and asset & property management. Our expertise covers multiple sectors including arts & culture commercial office, education, government, healthcare, hotels & resorts, industrial, military housing communities, mixed-use, multi-site, pharmaceutical, senior living, solar, transportation and aviation.

We create innovative and sustainable property solutions, forging partnerships and delivering maximum benefits to clients, investors and communities.  Safety is our number one priority and Lend Lease is committed to operating Incident & Injury Free wherever we have a presence.

SOURCE Lend Lease
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Luminex Corporation Fourth Quarter and Full Year 2011 Earnings Release Scheduled for February 6, 2012
2. As Released on 30 December, 2011: Novogen Modifies ADR Program and Makes Further Investment Into Marshall Edwards
3. HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
4. Verify Brand™ Announces the Release of VB Enterprise 4.0
5. Varian Medical Systems Schedules First Quarter FY2012 News Release and Conference Call
6. ICD-10 Coding Knowledge Assessment Tool Released
7. Dyadic International Announces Date and Time of Third Quarter 2011 Financial Results Release and Conference Call
8. Minimally Invasive Devices, Inc. Announces Release of FloShield™ PLUS
9. Ion Torrent Gets Better Faster With 4th Qtr New Product Releases
10. STAAR Surgical Announces Third Quarter 2011 Results Release Date and Conference Call
11. Life Technologies Sets 3rd Quarter 2011 Earnings Release Date for Tuesday, October 25, 2011
Post Your Comments:
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young ... cancer. Members of the Class of 2016 were selected from a pool of ... More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... ... In a new case report published today in STEM CELLS Translational Medicine, doctors ... being treated for breast cancer benefitted from an injection of stem cells derived from ... frequent side effect of cancer treatment. , Lymphedema refers to the swelling ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... exhibiting at the Pennsylvania Convention Center and will showcase its product’s latest features ... will also be presenting a scientific poster on Disrupting Clinical Trials in The ...
Breaking Biology Technology:
(Date:4/28/2016)... India , April 28, 2016 ... Infosys (NYSE: INFY ), and Samsung SDS, a ... that will provide end customers with a more secure, ... services.      (Logo: ) , ... services, but it also plays a fundamental part in enabling ...
(Date:4/26/2016)... India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a product ... and Onegini today announced a partnership to integrate ... solutions.      (Logo: ... to provide their customers enhanced security to access ...
(Date:4/19/2016)... April 20, 2016 The new ... a compact web-based "all-in-one" system solution for all door ... reader or the door interface with integration authorization management ... control systems. The minimal dimensions of the access control ... the building installations offer considerable freedom of design with ...
Breaking Biology News(10 mins):